•
OK
OKYO
OKYO Pharma Limited Ordinary Shares
yahoo--
Price Chart
Market Cap
78.23M
Volume
300.02K
52W High
$3.35
52W Low
$0.90
Open
$0.00
Prev Close
$2.15
Day Range
0.00 - 0.00
About OKYO Pharma Limited Ordinary Shares
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
Latest News
OKYO Pharma Announces Plans to Accelerate the Clinical Development of Urcosimod to Treat Neuropathic Corneal Pain
GlobeNewswire Inc.•Apr 30
OKYO Pharma Announces Chairman and CEO Acquire Shares
GlobeNewswire Inc.•Jan 31
OKYO Pharma Announces First Patient Dosed in the First Clinical Trial to Treat Neuropathic Corneal Pain
GlobeNewswire Inc.•Oct 23
OKYO Pharma CEO Interview to Air on Bloomberg TV
GlobeNewswire Inc.•Aug 23
OKYO Pharma Announces Chairman Acquires Shares
GlobeNewswire Inc.•Aug 23
OKYO Pharma Announces Chairman Acquires Shares
GlobeNewswire Inc.•Aug 21
OKYO Pharma Announces Promising Categorical Data from OK-101 Phase 2 Trial in Dry Eye Disease - GlobeNewswire
GlobeNewswire Inc.•Jul 10
OKYO Pharma Announces Upcoming Presentation of OK-101 Phase 2 Data for Dry Eye Disease at the Dry Horizons Symposium, a Partner Meeting of the Association for Research in Vision and Ophthalmology (ARVO)
GlobeNewswire Inc.•Apr 30